Table 1 Base-line characteristics of the patients (intention-to-treat population).
Characteristic* | Interferon and Ribavirin 6 mo (n = 40) | Ribavirin 6 mo (n = 40) | Placebo 6 mo (n = 37) |
|---|---|---|---|
Age – yr | 47 ± 12 | 48 ± 12 | 46 ± 12 |
Sex – M/F | 28/12 | 28/12 | 31/6 |
Serum ALT – times ULN | 3.8 ± 2.0 | 3.8 ± 2.0 | 3.7 ± 1.6 |
Serum HCV RNA† | |||
Copies/ml – log10 | 6.2 ± 0.8 | 6.3 ± 0.8 | 6.3 ± 0.7 |
≥2 × 106 copies/ml – % | 54 | 55 | 55 |
Genotype – n (%) | |||
1 | 29 (79) | 24 (62) | 28 (76) |
2 or 3 | 6 (16) | 11 (22) | 8 (23) |
other | 2 (5) | 4 (6) | 1 (3) |
Cirrhosis – n (%) | 18 (45) | 13 (33) | 14 (38) |